Article Details

ACC 2025: Cardiovascular Benefits of Semaglutide 2.4 mg Highlighted in Real-World Study

Retrieved on: 2025-04-01 19:41:00

Tags for this article:

Click the tags to see associated articles and topics

ACC 2025: Cardiovascular Benefits of Semaglutide 2.4 mg Highlighted in Real-World Study. View article details on hiswai:

Excerpt

... care had a significantly lower risk of major adverse cardiovascular ... long-term healthcare costs." 1. The double-blind, placebo-controlled ...

Article found on: www.patientcareonline.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo